Expression of raf Oncogenes Activates the PEA1 Transcription Factor Motif

LITERATURE CITED

• Angel, P., E. Allegretto, S. Okino, K. Hattori, W. J. Boyle, T. Hunter, and M. Karin. 1988. The jun oncogene encodes a sequence specific trans-activator similar to AP-1. Nature (London) 332:166–171.
   PubMed Web of Science ®Google Scholar
• Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729–739.
   PubMed Web of Science ®Google Scholar
• Beck, T. W., M. Huleihel, M. A. Gunnel, T. I. Bonner, and U. R. Rapp. 1987. The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus. Nucleic Acids Res, 15:595–609.
   PubMedGoogle Scholar
• Bohmann, D., T. J. Bos, A. Admon, T. Nishimura, P. K. Vogt, and R. Tjian. 1987. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386–1392.
   PubMed Web of Science ®Google Scholar
• Bos, T. J., D. Bohmann, H. Tsuchie, R. Tjian, and P. K. Vogt. 1988. v-jun encodes a nuclear protein with enhancer binding properties of AP-1. Cell 52:705–712.
   PubMedGoogle Scholar
• Heidecker, G., J. L. Cleveland, T. Beck, M. Huleihel, W. Kolch, S. M. Storm, and U. R. Rapp. 1989. Role of raf and myc oncogenes in signal transduction, p. 339–374. In N. Colburn (ed.), Genes and signal transduction in multistage carcinogenesis. Marcel Dekker, Inc., New York.
   Google Scholar
• Huleihel, M., M. Goldsborough, J. Cleveland, M. Gunnell, T. Bonner, and U. R. Rapp. 1986. Characterization of murine A-raf, a new oncogene related to the v-raf oncogene. Mol. Cell. Biol. 6:2655–2662.
   PubMedGoogle Scholar
• Imler, J. L., C. Schatz, C. Wasylyk, B. Chatton, and B. Wasylyk. 1988. A Ha-Ras responsive transcription element is also responsive to a tumour-promoter and serum. Nature (London) 332:275–278.
   PubMed Web of Science ®Google Scholar
• Imler, J. L., E. Ugarte, C. Wasylyk, and B. Wasylyk. 1988. v-jun is a transcriptional activator, but not in all cell-lines. Nucleic Acids Res. 16:3005–3012.
   PubMedGoogle Scholar
• Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741–752.
   PubMed Web of Science ®Google Scholar
• Maki, Y., T. J. Bos, C. Davis, M. Starbuck, and P. K. Vogt. 1987. Avian sarcoma virus 17 carries the jun oncogenes. Proc. Natl. Acad. Sci. USA 84:2848–2852.
   PubMed Web of Science ®Google Scholar
• Morrison, D. K., D. R. Kaplan, U. Rapp, and T. M. Roberts. 1988. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase c-raf phosphorylation and associated protein kinase activity. Proc. Natl. Acad. Sci. USA 85:8855–8859.
   PubMed Web of Science ®Google Scholar
• Piette, J., and M. Yaniv. 1987. Two different factors bind to the α-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers. EMBO J. 6:1331–1337.
   PubMedGoogle Scholar
• Rapp, U. R., T. I. Bonner, K. Moelling, H. W. Jansen, K. Bister, and J. Ihle. 1985. Genes and gene products involved in growth regulation of tumor cells. Recent Results Cancer Res. 99:221–236.
   PubMedGoogle Scholar
• Rapp, U. R., J. L. Cleveland, S. M. Storm, T. W. Beck, and M. Huleihel. 1987. Transformation by raf and myc oncogenes, p. 55–74. In S. A. Aaronson et al. (ed.), Oncogenes and cancer. VNU Science Press, b.v., Utrecht, The Netherlands.
   Google Scholar
• Rapp, U. R., M. D. Goldsborough, G. E. Mark, T. I. Bonner, J. Groffen, F. H. Reynolds, and J. R. Stephenson. 1983. Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc. Natl. Acad. Sci. USA 80:4218–4222.
   PubMed Web of Science ®Google Scholar
• Rapp, U. R., S. M. Storm, and J. L. Cleveland. 1987. Oncogenes: clinical relevance, p. 450–459. In R. Neth, R. C. Gallo, M. F. Greaves, and H. Kabisch (ed.), Modem trends in human leukemia. VII. Haemotology and blood transfusion, vol. 31. Springer-Verlag KG, Berlin.
   Google Scholar
• Rauscher, F. J., D. R. Cohen, T. Curran, T. J. Bos, P. K. Vogt, D. Bohmann, R. Tjian, and B. R. Franza. 1988. fos-associated protein p39 is the product of the jun proto-oncogene. Science 240:1010–1016.
   PubMed Web of Science ®Google Scholar
• Rauscher, F. J., L. C. Sambucetti, T. Curran, R. J. Distel, and B. M. Spiegelman. 1988. Common DNA binding site for fos protein complexes and transcription factor AP-1. Cell 52:471–480.
   PubMed Web of Science ®Google Scholar
• Smith, M. R., S. J. DeGudicibus, and D. W. Stacey. 1986. Requirement for ras-proteins during viral oncogene transformation. Nature (London) 320:540–543.
   PubMed Web of Science ®Google Scholar
• Wasylyk, C., J. L. Imler, J. Perez-Mutul, and B. Wasylyk. 1987. The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer. Cell 48:525–534.
   PubMed Web of Science ®Google Scholar
• Wasylyk, C., J. L. Imler, and B. Wasylyk. 1988. Transforming but not immortalising oncogenes activate the transcription factor PEA1. EMBO J. 7:2475–2483.
   PubMedGoogle Scholar
• Wasylyk, C., and B. Wasylyk. 1986. The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphocyte cells. EMBO J. 5:553–560.
   PubMed Web of Science ®Google Scholar